日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Osimertinib is a dual inhibitor of hepatocellular carcinoma and angiogenesis in an EGFR-independent manner, and synergizes with venetoclax.

奥希替尼是一种不依赖于 EGFR 的肝细胞癌和血管生成双重抑制剂,并且与维奈托克具有协同作用

Huang Qiaoxin, He Shengsong, Zhan Dongang

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection

SARS-CoV-2灭活疫苗在慢性乙型肝炎病毒感染患者中的安全性和免疫原性

Xiang, Tiandan; Liang, Boyun; Wang, Hua; Quan, Xufeng; He, Shengsong; Zhou, Helong; He, Yongwen; Yang, Dongliang; Wang, Baoju; Zheng, Xin

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

SARS-CoV-2感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征

Liu, Jing; Li, Sumeng; Liu, Jia; Liang, Boyun; Wang, Xiaobei; Wang, Hua; Li, Wei; Tong, Qiaoxia; Yi, Jianhua; Zhao, Lei; Xiong, Lijuan; Guo, Chunxia; Tian, Jin; Luo, Jinzhuo; Yao, Jinghong; Pang, Ran; Shen, Hui; Peng, Cheng; Liu, Ting; Zhang, Qian; Wu, Jun; Xu, Ling; Lu, Sihong; Wang, Baoju; Weng, Zhihong; Han, Chunrong; Zhu, Huabing; Zhou, Ruxia; Zhou, Helong; Chen, Xiliu; Ye, Pian; Zhu, Bin; Wang, Lu; Zhou, Wenqing; He, Shengsong; He, Yongwen; Jie, Shenghua; Wei, Ping; Zhang, Jianao; Lu, Yinping; Wang, Weixian; Zhang, Li; Li, Ling; Zhou, Fengqin; Wang, Jun; Dittmer, Ulf; Lu, Mengji; Hu, Yu; Yang, Dongliang; Zheng, Xin